Haroon Iqbal

机构：Chinese Academy of Sciences, Wenzhou Medical University, Soochow University, Affiliated Eye Hospital of Wenzhou Medical College, Hangzhou Academy of Agricultural Sciences · ORCID：0000-0002-7908-8804

发表论文 87 篇 · 总被引 1925 次 · h-index 24

代表论文

• Current trends in inhaled pharmaceuticals: challenges and opportunities in respiratory infections treatment (2025 · Journal of Pharmaceutical Investigation · 被引 14)
• Unveiling the potential of pulmonary surfactant-based nanocarriers for protein inhalation therapy (2024 · European Journal of Pharmaceutics and Biopharmaceutics · 被引 13)
• Engineered polyphenol-keratin nanocarriers enhance probiotic delivery and ameliorate obese ulcerative colitis (2025 · Colloids and Surfaces B Biointerfaces · 被引 10)
• Identification of a novel EphB4 inhibitor, Sanguinarine, which attenuates β-catenin signaling to inhibit tumor proliferation and migration in lung cancer (2026 · Journal of Advanced Research · 被引 7)
• Role of nanomedicines in lung cancer treatment and diagnosis: opportunities and challenges (2025 · Medical Oncology · 被引 7)
• Emerging roles and mechanisms of nanoparticles in cancer treatment: innovations and horizons (2026 · Biomedical Physics & Engineering Express · 被引 6)